SHZ · 000963.SZ
Huadong Medicine Co., Ltd
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
Loading market information…
SHZ · 300436.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Fujian Cosunter Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.47% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fujian Cosunter Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.10 per share, paid annual. The forward yield is 0.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fujian Cosunter Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2001 and headquartered in Fuzhou, China, Fujian Cosunter Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the pharmaceutical industry. The company is actively involved in the full spectrum of pharmaceutical operations, encompassing the research and development, production, and sale of medicinal products across China. Its core offerings comprise Chinese patent medicines, which are utilized in treating a variety of conditions, including liver ailments, men's health (andrology), cardiovascular disorders, and other therapeutic areas.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥26.61+CN¥0.73 (+2.82%)
Huadong Medicine Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥47.64+CN¥0.31 (+0.65%)
Dong-E-E-Jiao Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.37% below the high.
CN¥23.67+CN¥0.04 (+0.17%)
Guangdong Zhongsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.93% below the high.
CN¥19.00+CN¥0.10 (+0.53%)
Chengdu Kanghong Pharmaceutical Group Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 46.57% below the high.
CN¥15.19+CN¥0.60 (+4.11%)
Shandong Buchang Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.76% below the high.
CN¥11.99+CN¥0.20 (+1.7%)
Beijing Aosaikang Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.53% below the high.
CN¥10.96+CN¥0.22 (+2.05%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.23% below the high.
CN¥6.47+CN¥0.21 (+3.35%)
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.33% below the high.
